Atea Pharmaceuticals, Inc. (AVIR)

NMS – Real Time Price. Currency in USD

5.00

-0.05 (-0.99%)

Market open: Aug 12, 2026, 10:11 AM EDT

5.05

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 4:10 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

05.08.2026

Atea Pharmaceuticals to Host Second Quarter 2026 Financial Results and Business Update Conference Call on August 12, 2026

BOSTON, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a live conference call and audio webcast on Wednesday, August 12, 2026, at 4:30 p.m. ET to report financial results for the second quarter ended June 30, 2026, and to provide a business update.

Videos

No Data

There is no data to display

Atea Pharmaceuticals, Inc. (AVIR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Atea Pharmaceuticals, Inc. (AVIR)

Atea Pharmaceuticals to Host Second Quarter 2026 Financial Results and Business Update Conference Call on August 12, 2026

Videos

No Data

Atea Pharmaceuticals to Host Second Quarter 2026 Financial Results and Business Update Conference Call on August 12, 2026

Videos

No Data

Search stocks

Atea Pharmaceuticals, Inc. (AVIR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Atea Pharmaceuticals, Inc. (AVIR)

Atea Pharmaceuticals to Host Second Quarter 2026 Financial Results and Business Update Conference Call on August 12, 2026

Videos

No Data

Atea Pharmaceuticals to Host Second Quarter 2026 Financial Results and Business Update Conference Call on August 12, 2026

Videos

No Data